Inhibition of the allergic response by regulatory T cells

被引:47
作者
Stock, P
DeKruyff, RH
Umetsu, DT
机构
[1] Harvard Univ, Sch Med, Childrens Hosp, Div Immunol,Karp Labs, Boston, MA 02115 USA
[2] Univ Hosp Charite, Dept Pediat Pneumol & Immunol, Berlin, Germany
关键词
airway hyperresponsiveness; allergy; asthma; regulatory cells; tolerance;
D O I
10.1097/01.all.0000200502.69672.44
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Purpose of review Allergic diseases are caused by the overdevelopment of T-helper type 2 biased immune responses in susceptible individuals. A number of recent studies indicate that regulatory T cells play an important role in controlling such T-helper type 2 biased responses not only in animal models, but in humans as well, and these will be reviewed in this article. Recent findings A family of regulatory cells appears to be involved in regulating allergies. Both naturally occurring CD4(+)CD25(+) regulatory T cells and inducible forms of antigen-specific regulatory T cells, both expressing the transcription factor foxp3, have been shown to inhibit the inappropriate immune responses involved in allergic diseases. Impaired expansion of natural or adaptive regulatory T cells is hypothesized to lead to the development of allergy, and treatment to induce allergen-specific regulatory T cells could provide curative therapies for allergy and asthma. Summary Allergen-specific regulatory T cells play an important role in controlling the development of allergy and asthma.
引用
收藏
页码:12 / 16
页数:5
相关论文
共 63 条
[1]  
Akbari O, 2002, NAT MED, V8, P1024, DOI 10.1038/nm745
[2]   Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells [J].
Akdis, M ;
Verhagen, J ;
Taylor, A ;
Karamloo, F ;
Karagiannidis, C ;
Crameri, R ;
Thunberg, S ;
Deniz, G ;
Valenta, R ;
Fiebig, H ;
Kegel, C ;
Disch, R ;
Schmidt-Weber, CB ;
Blaser, K ;
Akdis, CA .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (11) :1567-1575
[3]   Toll-like receptor signalling [J].
Akira, S ;
Takeda, K .
NATURE REVIEWS IMMUNOLOGY, 2004, 4 (07) :499-511
[4]   The cellular mechanism of Aire control of T cell tolerance [J].
Anderson, MS ;
Venanzi, ES ;
Chen, ZB ;
Berzins, SP ;
Benoist, C ;
Mathis, D .
IMMUNITY, 2005, 23 (02) :227-239
[5]   In vivo instruction of suppressor commitment in naive T cells [J].
Apostolou, I ;
von Boehmer, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 2004, 199 (10) :1401-1408
[6]   Interleukin-10 therapy - Review of a new approach [J].
Asadullah, K ;
Sterry, W ;
Volk, HD .
PHARMACOLOGICAL REVIEWS, 2003, 55 (02) :241-269
[7]   In vitro generation of interleukin 10-producing regulatory CD4+ T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines [J].
Barrat, FJ ;
Cua, DJ ;
Boonstra, A ;
Richards, DF ;
Crain, C ;
Savelkoul, HF ;
de Waal-Malefyt, R ;
Coffman, RL ;
Hawrylowicz, CM ;
O'Garra, A .
JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (05) :603-616
[8]   Allergen immunotherapy:: therapeutic vaccines for allergic diseases [J].
Bousquet, J ;
Lockey, R ;
Malling, HJ ;
Alvarez-Cuesta, E ;
Canonica, GW ;
Chapman, MD ;
Creticos, PJ ;
Dayer, JM ;
Durham, SR ;
Demoly, P ;
Goldstein, RJ ;
Ishikawa, T ;
Ito, K ;
Kraft, D ;
Lambert, PH ;
Lowenstein, H ;
Müller, U ;
Norman, PS ;
Reisman, RE ;
Valenta, R ;
Valovirta, E ;
Yssel, H .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 1998, 81 (05) :401-405
[9]   Epicutaneous immunization with autoantigenic peptides induces T suppressor cells that prevent experimental allergic encephalomyelitis [J].
Bynoe, MS ;
Evans, JT ;
Viret, C ;
Janeway, CA .
IMMUNITY, 2003, 19 (03) :317-328
[10]   Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3 [J].
Chen, WJ ;
Jin, WW ;
Hardegen, N ;
Lei, KJ ;
Li, L ;
Marinos, N ;
McGrady, G ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 2003, 198 (12) :1875-1886